ESLICARBAZEPINE ACETATE
Generic: ESLICARBAZEPINE ACETATE
Aurobindo Pharma LimitedManufacturer
ORALRoute
ESLICARBAZEPINE ACETATEActive Substance
2026-08-05Original Approval
ESLICARBAZEPINE ACETATE is FDA application ANDA216481, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
137 reports
2
SEIZURE
116 reports
3
OFF LABEL USE
104 reports
4
CONDITION AGGRAVATED
56 reports
5
HYPONATRAEMIA
52 reports
6
SOMNOLENCE
48 reports
7
PRODUCT USE IN UNAPPROVED INDICATION
42 reports
8
DIZZINESS
41 reports
9
GENERALISED TONIC-CLONIC SEIZURE
34 reports
10
UNDERDOSE
34 reports